P. Moreillon

984 total citations
27 papers, 756 citations indexed

About

P. Moreillon is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, P. Moreillon has authored 27 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in P. Moreillon's work include Antimicrobial Resistance in Staphylococcus (15 papers), Infective Endocarditis Diagnosis and Management (11 papers) and Bacterial Identification and Susceptibility Testing (5 papers). P. Moreillon is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (15 papers), Infective Endocarditis Diagnosis and Management (11 papers) and Bacterial Identification and Susceptibility Testing (5 papers). P. Moreillon collaborates with scholars based in Switzerland, Netherlands and Germany. P. Moreillon's co-authors include P Francioli, José M. Entenza, Pierre Vaudaux, Timothy J. Foster, Patrice François, Damien McDevitt, M. P. Glauser, M. P. Glauser, H Drugeon and C. Daniel Overholser and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

P. Moreillon

26 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Moreillon Switzerland 13 549 308 235 202 140 27 756
G. Dimitracopoulos Greece 17 319 0.6× 330 1.1× 156 0.7× 95 0.5× 128 0.9× 51 769
Marcelo de Carvalho Ramos Brazil 12 405 0.7× 248 0.8× 243 1.0× 96 0.5× 39 0.3× 30 789
M. Campa Italy 15 271 0.5× 148 0.5× 280 1.2× 86 0.4× 68 0.5× 61 801
Eric R. McIndoo United States 8 434 0.8× 174 0.6× 109 0.5× 256 1.3× 154 1.1× 15 584
Peter‐Michael Rath Germany 20 640 1.2× 171 0.6× 635 2.7× 87 0.4× 99 0.7× 73 1.2k
S. Å. HEDSTRÖM Sweden 14 306 0.6× 140 0.5× 201 0.9× 181 0.9× 79 0.6× 30 567
Nanae Aritaka Japan 7 919 1.7× 520 1.7× 158 0.7× 129 0.6× 535 3.8× 14 1.2k
D. L. Weinbaum United States 10 608 1.1× 131 0.4× 326 1.4× 147 0.7× 443 3.2× 15 1.1k
Marie B. Coyle United States 15 505 0.9× 196 0.6× 278 1.2× 106 0.5× 164 1.2× 21 870
Wataru Higuchi Japan 23 1.2k 2.1× 857 2.8× 210 0.9× 314 1.6× 522 3.7× 58 1.5k

Countries citing papers authored by P. Moreillon

Since Specialization
Citations

This map shows the geographic impact of P. Moreillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Moreillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Moreillon more than expected).

Fields of papers citing papers by P. Moreillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Moreillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Moreillon. The network helps show where P. Moreillon may publish in the future.

Co-authorship network of co-authors of P. Moreillon

This figure shows the co-authorship network connecting the top 25 collaborators of P. Moreillon. A scholar is included among the top collaborators of P. Moreillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Moreillon. P. Moreillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernsmeier, Christine, et al.. (2012). Daptomycin for highly resistant Enterococcus faecium infection. Swiss Medical Weekly. 142(2526). w13603–w13603. 3 indexed citations
2.
Delodder, Frederik, Lucas Liaudet, Yi Que, et al.. (2010). Pancreatic stone protein (PSP): a biomarker of sepsis. IRIS. 1 indexed citations
3.
Moreillon, P., et al.. (2006). [Infective endocarditis and outpatient practice].. PubMed. 2(60). 903–6, 908. 1 indexed citations
4.
Blanc, Dominique, Didier Pittet, C. Ruef, et al.. (2002). Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. Clinical Microbiology and Infection. 8(7). 419–426. 24 indexed citations
5.
Bochud, Pierre–Yves, Thierry Calandra, P. Moreillon, J. D. Baumgartner, & Bertrand Yersin. (2001). Breakthrough Streptococcus pneumoniae Meningitis During Clarithromycin Therapy for Acute Otitis Media. European Journal of Clinical Microbiology & Infectious Diseases. 20(2). 136–137. 5 indexed citations
6.
Meier, Patricia Stutzmann, José M. Entenza, Pierre Vaudaux, et al.. (2001). Study of Staphylococcus aureus Pathogenic Genes by Transfer and Expression in the Less Virulent Organism Streptococcus gordonii. Infection and Immunity. 69(2). 657–664. 45 indexed citations
7.
Moreillon, P.. (2001). [Experimental models: interactions Synercid and beta-lactam antibiotics].. PubMed. 30(25 Pt 2). X–XIV. 2 indexed citations
8.
Moreillon, P.. (2000). [Means of bacterial resistance].. PubMed. 120(8). 641–50. 9 indexed citations
9.
Foster, Timothy J., et al.. (2000). Contribution of Clumping Factor B to Pathogenesis of Experimental Endocarditis due to Staphylococcus aureus. Infection and Immunity. 68(9). 5443–5446. 61 indexed citations
10.
Caldelari, Isabelle, et al.. (2000). Deregulation of the Arginine Deiminase ( arc ) Operon in Penicillin-Tolerant Mutants of Streptococcus gordonii. Antimicrobial Agents and Chemotherapy. 44(10). 2802–2810. 16 indexed citations
11.
Moreillon, P., Aline Wenger, & Isabelle Caldelari. (2000). [Pneumococcal antibiotic resistance].. PubMed. 120(8). 651–9. 5 indexed citations
12.
Entenza, José M., Isabelle Caldelari, M. P. Glauser, P Francioli, & P. Moreillon. (1997). Importance of Genotypic and Phenotypic Tolerance in the Treatment of Experimental Endocarditis Due to Streptococcus gordonii. The Journal of Infectious Diseases. 175(1). 70–76. 19 indexed citations
13.
Entenza, José M., et al.. (1996). Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy. 40(3). 809–811. 9 indexed citations
14.
Moreillon, P. & Aline Wenger. (1996). [Antibiotic resistance in pneumococci].. PubMed. 126(7). 255–63. 4 indexed citations
15.
Flückiger, Ursula, et al.. (1995). Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Médecine et Maladies Infectieuses. 25(10). 1040–1040. 1 indexed citations
16.
Drugeon, H, et al.. (1995). Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrobial Agents and Chemotherapy. 39(7). 1419–1424. 62 indexed citations
17.
L’Hériteau, F., et al.. (1995). RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrobial Agents and Chemotherapy. 39(7). 1425–1429. 9 indexed citations
18.
Flückiger, Ursula, et al.. (1994). Antibiotic Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis. The Journal of Infectious Diseases. 170(1). 100–109. 21 indexed citations
19.
Moreillon, P., et al.. (1990). Determinación de la grasa corporal mediante densitometría y antropometría en niños de siete a diez años. Anales de Pediatría. 32(2). 109–113.
20.
Boelaert, Johan R., H.W. Van Landuyt, Y. Valcke, et al.. (1987). The Role of Iron Overload in Yersinia enterocolitica and Yersinia pseudotuberculosis Bacteremia in Hemodialysis Patients. The Journal of Infectious Diseases. 156(2). 384–387. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026